Zhejiang Starry Pharmaceutical Co.,Ltd.’s Net Profit Dropped 49.1% in First Half of 2023

Zhejiang Starry Pharmaceutical Co.,Ltd. (浙江司太立制药股份有限公司) (603520.SH) reported a net profit of 35.3 million yuan in the first half of 2023, down 49.1% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 15% year-on-year.

At the end of the reporting period, it had 5.5 billion yuan in total assets and 3.7 billion yuan in total liabilities, with a liability-to-asset ratio of 67.9%.